Actualités Takeda Pharmaceutical Co Ltd - 0RN3 | Actions London Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Taked ...

TOP NEWS: Takeda lifts outlook, eyes return to sustainable growth

Takeda Pharmaceutical Co Ltd on Thursday raised full year forecasts to reflect a stronger than anticipated first-half ...

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. The drug has bee ...

IN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla

Ltd - Hong Kong-headquartered biopharmaceutical company - Notes that Takeda Pharmaceuticals Co Ltd received a notifica ...

TOP NEWS: Takeda Pharmaceutical profit sinks as expenses mount

Takeda Pharmaceutical Co Ltd on Thursday said annual revenue increased, though profit plummeted on increased expenses ...

Takeda, Astellas and Sumitomo to create new drug discovery company

Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc and Sumitomo Mitsui Financial Group Inc on Monday agreed to establi ...

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE PR...

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE PR...

Hutchmed hails Takeda's fruquintinib approval from US for cancer form

Hutchmed (China) Ltd on Thursday announced that the Tokyo-based drug maker, Takeda Pharmaceutical Co Ltd, has receive ...

Takeda Pharmaceutical first half profit falls as costs outpace revenue

Takeda Pharmaceutical Co Ltd on Monday said profit fell in the first half of its financial year, despite revenue risi ...

Hutchmed notes Takeda submits fruquintinib drug application in Japan

Hutchmed (China) Ltd on Friday said Takeda Pharmaceutical Co Ltd has submitted a new drug application for cancer trea ...

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Takeda Pharmaceutical Co Ltd (0RN3)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

0RN3 Actualités

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

TOP NEWS: Takeda lifts outlook, eyes return to sustainable growth

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

IN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla

TOP NEWS: Takeda Pharmaceutical profit sinks as expenses mount

Takeda, Astellas and Sumitomo to create new drug discovery company

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Hutchmed hails Takeda's fruquintinib approval from US for cancer form

Takeda Pharmaceutical first half profit falls as costs outpace revenue

Hutchmed notes Takeda submits fruquintinib drug application in Japan

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Takeda keeps guidance unchanged despite drop in quarterly profit

Japan's Takeda pulls dengue vaccine candidate in US

Japan's Takeda pulls dengue vaccine candidate in US

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Takeda Pharmaceutical Co Ltd (0RN3) Actualités

Takeda Pharmaceutical Co Ltd (0RN3)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

0RN3 Actualités

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

TOP NEWS: Takeda lifts outlook, eyes return to sustainable growth

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

IN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla

TOP NEWS: Takeda Pharmaceutical profit sinks as expenses mount

Takeda, Astellas and Sumitomo to create new drug discovery company

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Hutchmed hails Takeda's fruquintinib approval from US for cancer form

Takeda Pharmaceutical first half profit falls as costs outpace revenue

Hutchmed notes Takeda submits fruquintinib drug application in Japan

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Takeda keeps guidance unchanged despite drop in quarterly profit

Japan's Takeda pulls dengue vaccine candidate in US

Japan's Takeda pulls dengue vaccine candidate in US

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres